Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Computing
Conference & Expo
November 2-4, 2009 NYC
Register Today and SAVE !..

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
SYS-CON.TV
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Highly Acclaimed MD Joins Company's Leadership Team

HUNTINGTON BEACH, Calif., Jan. 8, 2013 /PRNewswire/ -- Absorption Pharmaceuticals, makers of the world's first FDA-Approved topical treatment for premature ejaculation, Promescent, announced today that Laurence A. Levine, MD will assume the role of Chief Medical Officer (CMO). Dr. Levine will oversee the company's growth and education efforts, with a focus on getting Promescent written into protocols as a top-line treatment for premature ejaculation nationwide.  

"We're thrilled to have such a highly respected and knowledgeable physician join our team," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "We have been growing rapidly due to Promescent's proven effectiveness and securing Dr. Levine– whom has already provided invaluable assistance in reaching key opinion leaders in sexual medicine– adds to the credibility of this revolutionary product in the sexual medicine category. We look forward to the ongoing adoption of Promescent as the primary medical solution for premature ejaculation."  

Dr. Levine received his medical degree from the University of Colorado Medical School, followed by a residency in general surgery at Tufts-New England Medical Center and in urology at the Harvard Program in Urology at Brigham and Women's Hospital in Boston.  He has made a substantial contribution to the medical press in the form of peer-reviewed articles, books, book chapters, and Internet publications regarding male sexual dysfunction, fertility, chronic orchialgia and reconstructive urology. Currently, Dr. Levine is a professor  of urology at the Rush University Medical Center in Chicago, and is in private practice with Uropartners, LLC. He has received multiple awards and honors; and served as a past-president of the Sexual Medicine Society of North America and the Chicago Urological Society.

"I am very excited to join Absorption Pharmaceuticals as Chief Medical Officer," says Dr. Levine. "Promescent is a ground-breaking, unrivaled product and doctors across the country are delighted to have a solution to a problem that previously has not received the attention it deserves. As an early adopter of the product as treatment for my patients with PE, I'm proud to lead the charge in spreading awareness of Promescent to the medical community."

Created by a urologist, Promescent is a lidocaine-based spray for premature ejaculation designed to absorb below the surface of the skin where nerve endings that control ejaculation are located, ultimately prolonging the time period of intercourse.

Promescent is available through doctors' offices, pharmacies and online at www.promescent.com.

For more information on Dr. Levine, go to www.urologyspecialists.net/meetus.html.

About Absorption Pharmaceuticals:

Absorption Pharmaceuticals is the maker of Promescent, the world's first FDA-approved topical treatment for premature ejaculation.  Based in Huntington Beach, California, the company was founded in 2011 and has seen tremendous growth including distribution in doctors' offices, pharmacies, and online at www.promescent.com.

For more information contact:
Susan Weingram
sweingram@5wpr.com 
Tel: 212-584-4271

SOURCE Absorption Pharmaceuticals

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

SOA World Latest Stories
More and more file-based and machine generated data is being created every day causing exponential data and content growth, and creating a management nightmare for IT managers. What data centers really need to cope with this growth is a purpose-built tiered archive appliance that enabl...
Software is eating the world. Companies that were not previously in the technology space now find themselves competing with Google and Amazon on speed of innovation. As the innovation cycle accelerates, companies must embrace rapid and constant change to both applications and their inf...
In this challenging environment, a combination of automated integration testing and test virtualization can enable test teams to improve software quality and keep up with the rate of change. This white paper helps address these needs by describing the benefits that can be gained throug...
With the capability to reduce both CapEx and OpEx, it’s easy to see why the SDN-NFV trend has taken hold in the hosting and mobile industry. Early use cases include network virtualization from cloud service providers and enterprise data centers, bandwidth calendaring and network tappin...
The Domain Name Service (DNS) is one of the most important components in networking infrastructure, enabling users and services to access applications by translating URLs (names) into IP addresses (numbers). Because every icon and URL and all embedded content on a website requires a DN...
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is ob...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE